Stanley Alkemade
Fundador en Worldwide BioMedEx, Inc. .
Perfil
Stanley Alkemade is the founder of Worldwide BioMedEx, Inc. He is currently the President of BiomedEx Pty Ltd.
His former positions include Chief Executive Officer at Viron Therapeutics, Inc. and Director at NovaVive, Inc. He was also an Independent Non-Executive Director at Telesta Therapeutics, Inc. from 2013 to 2013.
Dr. Alkemade holds a doctorate degree from the University of Melbourne.
Cargos activos de Stanley Alkemade
| Empresas | Cargo | Inicio |
|---|---|---|
| BiomedEx Pty Ltd. | Presidente | - |
| Worldwide BioMedEx, Inc. | Fundador | - |
Antiguos cargos conocidos de Stanley Alkemade.
| Empresas | Cargo | Fin |
|---|---|---|
| TELESTA THERAPEUTICS INC | Director/Miembro de la Junta | 05/11/2013 |
NovaVive, Inc.
 NovaVive, Inc. BiotechnologyHealth Technology NovaVive, Inc. provides biotechnology services. The company was founded in 2014 and is headquartered in Belleville, Canada. | Director/Miembro de la Junta | - |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Presidente | - |
Formación de Stanley Alkemade.
| University of Melbourne | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |
| BiomedEx Pty Ltd. | |
| Worldwide BioMedEx, Inc. | |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Health Technology |
NovaVive, Inc.
NovaVive, Inc. BiotechnologyHealth Technology NovaVive, Inc. provides biotechnology services. The company was founded in 2014 and is headquartered in Belleville, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Stanley Alkemade
